Get early access! Join the Twelve Data AI Assistant waitlist now.

CATX

3.38000 USD
0.23
6.37%
Last update Aug 28, 3:59 PM EDT
Market closed
Day range
3.35500
3.66000
Previous close
3.61000
Open
3.65000
Access this stock data via API
Subscribe
Perspective Therapeutics Inc.
3.38
0.23
6.37%

Overview

Description

Perspective Therapeutics Inc. is a biotechnology company focused on the discovery, development, and commercialization of innovative therapeutics and technologies to treat various diseases, primarily within the oncology sector. Its primary function is to advance research that can lead to practical cancer treatment solutions, potentially impacting patient care significantly. The company engages in developing novel targeted therapies, often collaborating with leading research institutions and utilizing cutting-edge scientific techniques. Perspective Therapeutics Inc. plays a critical role in the healthcare market by addressing unmet medical needs and contributing to the growing demand for personalized medicine approaches. The work undertaken by the company holds substantial importance for the biotech and pharmaceutical industries as it seeks to improve therapeutic outcomes and enhance medical capabilities in combating cancer and other serious illnesses. The company's initiatives not only underscore the importance of biotechnology in advancing healthcare solutions but also highlight the ongoing evolution within the medical research landscape.

About

CEO
Mr. Johan M. Spoor
Employees
138
Address
2401 Elliott Avenue
Suite 320
Seattle, 98121, WA
United States
Phone
206 676 0900
Instrument type
Common stock
Sector
Healthcare
Industry
Medical Devices
Country
United States
MIC code
XASE
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 30 minutes

20:29
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).